Lessons from COVID-19 Pandemic: A Successful Policy and Practice by Pasteur Institute of Iran

Authors
Mona Sadat Larijani 1
Alireza Biglari 2
Rahim Sorouri 3
Mostafa Salehi-Vaziri 4
Delaram Doroud 5
Keyhan Azadmanesh 6
Fatemeh Fotouhi 7
Ehsan Mostafavi 8
Amitis Ramezani* 1
1 Clinical Research Department, Pasteur Institute of Iran, Tehran, Iran
2 School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3 IPI Directorate, Pasteur Institute of Iran, Tehran, Iran
4 COVID-19 National Reference Laboratory, Pasteur Institute of Iran, Tehran, Iran
5 Quality Control Department, Production and research Complex, Pasteur Institute of Iran, Tehran, Iran
6 Department of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran
7 Department of Influenza and Other Respiratory Viruses, Pasteur Institute of Iran, Tehran, Iran
8 Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran
10.61186/ibj.3964
Abstract
The present study aims to provide an insight to the comprehensive efforts of Pasteur Institute of Iran (PII) regarding COVID-19 management, research, achievements, and vaccine production, though there are many challenges. The relevant literature review was investigated through national and international database and also reports from the related research departments. Six strategies were taken by PII to manage the pandemic of COVID-19. While this pandemic has been hopefully controlled, SARS-CoV-2 could still be a potential threat. Therefore, COVID-19 data management and updated studies, as well as long-term safety and efficacy of the SARS-CoV-2 vaccines are still on the agenda.
Keywords
Pasteur Institute of Iran
COVID-19
Public Health management
Vaccine